The<unk>  is a national<unk><unk>  network sponsored by the National Cancer Institute (NCI) that consists of about 10,000 cancer specialists at hospitals, medical centers, and community clinics across the United States and Canada. The<unk>  develops and conducts<unk><unk>  with promising new cancer therapies, and utilizes scientific research to develop treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments. The<unk>  seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. The<unk>  conducts<unk>  in the following disease and modality areas: breast, gastrointestinal (GI), genitourinary (GU), leukemia, lymphoma, myeloma, neuro-oncology, respiratory, experimental therapeutics (rare cancers), cancer control and transplant. The<unk>  was formed by the merger of three legacy<unk><unk>  groups: the American College of Surgeons<unk>  Group (ACOSOG), the Cancer and Leukemia Group B (CALGB), and the North Central Cancer Treatment Group (NCCTG). The merger was completed in 2014.
Alliance for Clinical Trials in Oncology
NCI-designated Cancer Center
European Organisation for Research and Treatment of Cancer
Cancer Research UK
American Association for Cancer Research
Personalized onco-genomics
Molecular tumor board
Comparative oncology